Peter Knudsen brings a combination of business acumen and patent strategy to his biotechnology and academic clients. He represents companies at every stage of growth, from large pharmaceutical companies to start-ups.

His practice focuses on the development of patent platforms for:

• New drugs (including proteins)
• New biologics (including nanoparticle formulations for delivery of proteins and nucleic acids)
• Nanoparticle manufacturing
• Genetically modified organisms, including plants and mammals, and plants produced by conventional hybridization and/or natural selection

Peter also provides IP strategy and counseling support, including:

• Development and management of IP portfolios covering therapies based on both traditional drugs and biologics
• Clearance and due diligence analysis for advisory opinions and IP strategy
• IP ownership issues, including contractual relations with business partners, research collaborators, CROs, and government contracts

On the academic side, Peter supports a range of patent procurement projects, including:

• Cell-based immunotherapies
• Diagnostic systems based on miRNA and gene sequencing, including diagnostic and prognostic models for cancer
• Drugs and methods for modulating energy metabolism
• Viral vectors for novel gene therapies, including knockdown of expression and immunomodulation

Before joining Outside GC, Peter was a partner for nearly 20 years at Baker Hostetler (and its predecessor firm) in Seattle, where he was responsible for developing and managing patent portfolios for biotechnology clients. Prior to Baker Hostetler, Peter was Vice President, Intellectual Property for Nanotech Pharmaceutical and MDRNA, a NASDAQ-listed biotechnology company. Before becoming a lawyer, Peter was on the faculty at Columbia University and at Harvard University, where he managed and directed research in molecular immunology and virology.

Peter received his law degree from St. John’s University, and his undergraduate degree in psychology and his Ph.D. in biophysics from UC Berkeley. Peter is admitted to practice in Washington State and New York State, and before the United States Patent and Trademark Office, the Federal Circuit Court of Appeals and the United States Supreme Court.